Related Links
Current Releases
Stock Quote
Standard & Poor's
SEC Filings
Mailing List
Releases Archives
Opexa Therapeutics Headlines
11/08/2004 - 12:17 PM
PharmaFrontiers Completes Acquisition of Multiple Sclerosis Cell Therapy Developer Opexa Pharmaceuticals Inc.
10/08/2004 - 09:04 AM
PharmaFrontiers Acquires Multiple Sclerosis Cell Therapy Developer Opexa Pharmaceuticals, Inc.
09/21/2004 - 04:19 PM
PharmaFrontiers Appoints David B. McWilliams CEO; Brian E. Rodriguez Named Director, Head of Audit Committee
Releases Archives
